Renee Kramer, MPH, University of Wisconsin-Madison

Provision of long-acting reversible contraceptives (LARCs) before women leave the delivery hospital can be difficult for health care systems to achieve due to the high costs of devices and insertion. In response to challenges with the global fee for labor and delivery services, 37 states since 2012 have established mechanisms to provide appropriate reimbursement for ...Read more >

Amy Collins, MD, University of Pittsburgh

Young transgender men (including young people who are transmasculinizing) face disparities in the provision of reproductive health care including contraception, despite their biologic capacity for pregnancy and evidence that this population has a need and desire for these critical services. There is a paucity of evidence describing the contraceptive preferences of transmasculine patients, with almost ...Read more >

Lindsey Yates, MPH, University of North Carolina at Chapel Hill

Black women in the US are more likely to experience unintended and short-interval pregnancies, which are associated with increased risk of adverse birth outcomes for mothers and infants. Long-acting reversible contraception (LARC), including the placement of intrauterine devices (IUDs) or implants, is the most effective contraceptive method for reducing unintended and short-interval pregnancies; however, Black ...Read more >

Summer Martins, PhD, MPH, University of Minnesota

Motivation for contraceptive use hinges on the user’s assumption that they are fertile—capable of conceiving or impregnating. The idea of infertility carries anxiety and stigma for many and, with no way to validate fertility other than attempting pregnancy, may cause people to doubt their reproductive capacity and need for contraception even though they have no ...Read more >

Ashley White, MSPH, University of South Carolina

Despite the method’s effectiveness and safety, vasectomy remains an underutilized contraceptive method in the US. National data has shown there are significant disparities in vasectomy use based on men’s racial/ethnic identity, education, and income, however, questions remain about why these differences exist. Currently, there is limited empirical data on men’s views on vasectomy to help ...Read more >

Alexandra Calderon, BA, University of California, Davis

Alexandra Calderon is a second year medical student at the University of California, Davis School of Medicine. As a Spanish-speaking, first-generation Latina immigrant, Alexandra looks forward to becoming a clinician able to provide comprehensive health care, including reproductive health services, to underserved families. Alexandra completed her BA in English Literature at the California State University, ...Read more >

Chinelo Okigbo, MD, PhD, MPH, University of North Carolina at Chapel Hill

Objective: Pre-gestational diabetes increases the risks of adverse maternal and neonatal pregnancy outcomes such as preeclampsia, preterm delivery, neonatal macrosomia, and birth defects. These risks are further increased if the pregnancy was unplanned. This study aims to examine the prevalence, predictors, and consequences of unplanned pregnancy among women of reproductive age with pre-gestational diabetes in ...Read more >

Anna Chatillon-Reed, MA, University of California, Santa Barbara

Anna Chatillon is a doctoral candidate in sociology at the University of California, Santa Barbara concentrating on reproduction, race, gender, and intersectionality. Her research traces the connections among reproductive healthcare policy and provision, women’s organizing, and intersecting structures of marginalization. Prior to entering graduate school, Anna worked as the Director of Policy and Advocacy for ...Read more >

Jaih Craddock, PhD, MSW, MA, University of Maryland, Baltimore

Dr. Craddock will develop her research skills and leadership in the field of family planning research.

Sadia Haider, MD, MPH, University of Chicago

There is an urgent need for effective HIV prevention tools for African American (AA) women, a population disproportionately impacted by HIV/AIDS health disparities. Approved by the Food and Drug Administration in 2012 for use by HIV-negative persons, pre-exposure prophylaxis (PrEP) is a promising biomedical prevention strategy that has the potential to reduce HIV incidence among ...Read more >

1 2 3 6